Sven Cichon, Thomas W Mühleisen, Franziska A Degenhardt, Manuel Mattheisen, Xavier Miró, Jana Strohmaier, Michael Steffens, Christian Meesters, Stefan Herms, Moritz Weingarten, Lutz Priebe, Britta Haenisch, Michael Alexander, Jennifer Vollmer, René Breuer, Christine Schmäl, Peter Tessmann, Susanne Moebus, H-Erich Wichmann, Stefan Schreiber, Bertram Müller-Myhsok, Susanne Lucae, Stéphane Jamain, Marion Leboyer, Frank Bellivier, Bruno Etain, Chantal Henry, Jean-Pierre Kahn, Simon Heath, Marian Hamshere, Michael C O'Donovan, Michael J Owen, Nick Craddock, Markus Schwarz, Helmut Vedder, Jutta Kammerer-Ciernioch, Andreas Reif, Johanna Sasse, Michael Bauer, Martin Hautzinger, Adam Wright, Philip B Mitchell, Peter R Schofield, Grant W Montgomery, Sarah E Medland, Scott D Gordon, Nicholas G Martin, Omar Gustafsson, Ole Andreassen, Srdjan Djurovic, Engilbert Sigurdsson, Stacy Steinberg, Hreinn Stefansson, Kari Stefansson, Lejla Kapur-Pojskic, Liliana Oruc, Fabio Rivas, Fermín Mayoral, Alexander Chuchalin, Gulja Babadjanova, Alexander S Tiganov, Galina Pantelejeva, Lilia I Abramova, Maria Grigoroiu-Serbanescu, Carmen C Diaconu, Piotr M Czerski, Joanna Hauser, Andreas Zimmer, Mark Lathrop, Thomas G Schulze, Thomas F Wienker, Johannes Schumacher, Wolfgang Maier, Peter Propping, Marcella Rietschel, Markus M Nöthen
We conducted a genome-wide association study (GWAS) and a follow-up study of bipolar disorder (BD), a common neuropsychiatric disorder. In the GWAS, we investigated 499,494 autosomal and 12,484 X-chromosomal SNPs in 682 patients with BD and in 1300 controls. In the first follow-up step, we tested the most significant 48 SNPs in 1729 patients with BD and in 2313 controls. Eight SNPs showed nominally significant association with BD and were introduced to a meta-analysis of the GWAS and the first follow-up samples...
March 11, 2011: American Journal of Human Genetics